NuVasive Receives Premarket Approval of Cervical Spine Disc System

NuVasive has received premarket approval of its PCM Cervical Disc System from the FDA.

Advertisement

The PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7. The device is implanted using an anterior approach. Patients should have failed at least six weeks of conservative treatment prior to implantation.

More Articles on Orthopedic Devices:

New Instrumentation & Partnership for DePuy Synthes Spine
DePuy Synthes Spine Launches Minimally Invasive Posterior-Lateral Fusion System
10 Orthopedic Device Company Acquisitions

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.